ABG Analytics logo
 

AbbVie Inc (NYSE: ABBV)

DRUGS - Drug Manufacturers - Major
Sector: Health Care
Stock price data as of 02/16/2024
Closing price: 177.49
Support price level: $161.11
Resistance price level: N/A
Relative strength index (14-day RSI) 86.7
Beta 0.20
  • ABBV is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.

  • The price of this low-beta stock is expected to increase by 0.20% for every 1% increase in the S&P-500.

  • Volatility is forecast to fall over the next month.

  • With RSI > 70, ABBV is overbought. Odds slightly favor a short-term price reversal.

  • Price broke above prior resistance level - a short-term bullish signal.

Low High Price as % of Range
$132.51 $177.49 100.0%
200 day 50 day 20 day 10 day
$148.40 $162.13 $169.97 $174.33
(Annualized standard deviation)
Historical
(5 year)
Last month Current estimate Next month forecast
25.6% 21.4% 21.0% 24.7%
There is an estimated 5% probability that the stock price of AbbVie Inc will fall by more than:
  • 5.7% in the next week.

  • 14.0% in the next month.

  • 38.0% in the next year.